Terms: = Prostate cancer AND PPP2R1A, PR65A, 5518, ENSG00000105568, MGC786, P30153 AND Clinical Outcome
1 results:
1. outcome of primary androgen deprivation therapy in super-elderly men with localized high-risk prostate cancer.
Yamamoto Y; Akashi Y; Kiba K; Hirayama A; Uemura H
Anticancer Drugs; 2022 Jul; 33(6):534-538. PubMed ID: 35276692
[TBL] [Abstract] [Full Text] [Related]
